These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2771995)

  • 1. Future clinical research on the use of BCG for bladder cancer.
    Morales A; Nickel JC
    Prog Clin Biol Res; 1989; 310():361-9. PubMed ID: 2771995
    [No Abstract]   [Full Text] [Related]  

  • 2. [BCG therapy. Its role in the treatment of tumors of the bladder].
    Patard JJ; Chopin DK; Abbou CC
    Ann Urol (Paris); 1995; 29(5):292-3. PubMed ID: 8638911
    [No Abstract]   [Full Text] [Related]  

  • 3. [ BCG-immunotherapy and bladder cancer].
    Rischmann P
    Prog Urol; 2008 May; 18 Suppl 5():S93. PubMed ID: 18585633
    [No Abstract]   [Full Text] [Related]  

  • 4. BCG in bladder cancer.
    Meek D
    Nurs Times; 1994 Oct 26-Nov 1; 90(43):34-5. PubMed ID: 7984457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCG immunization: review of past experience, current use, and future prospects.
    Brewer TF; Wilson ME; Nardell EA
    Curr Clin Top Infect Dis; 1995; 15():253-70. PubMed ID: 7546371
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravesical chemotherapy in non-muscle-invasive bladder cancer: what schedule and duration of treatment?
    Sylvester RJ
    Eur Urol; 2007 Oct; 52(4):951-3; discussion 953-4. PubMed ID: 17374437
    [No Abstract]   [Full Text] [Related]  

  • 7. Superficial bladder cancer--treatment approach.
    Abi-Aad A; Biquet P; Penders L
    Acta Urol Belg; 1996 May; 64(2):19-24. PubMed ID: 8701801
    [No Abstract]   [Full Text] [Related]  

  • 8. BCG in carcinoma in situ and superficial bladder tumors.
    Lamm DL
    Prog Clin Biol Res; 1988; 269():497-510. PubMed ID: 3293069
    [No Abstract]   [Full Text] [Related]  

  • 9. Complications of bacillus Calmette-Guerin (BCG) immunotherapy in superficial bladder cancer.
    Sosnowski JT
    Compr Ther; 1994; 20(12):695-701. PubMed ID: 7882653
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of flat carcinoma in situ of the bladder.
    Whitmore WF
    Prog Clin Biol Res; 1984; 162B():219-24. PubMed ID: 6504897
    [No Abstract]   [Full Text] [Related]  

  • 11. BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancer.
    Schreinemachers L; Van der Meyden A; Steerenberg P; Feitz W; Groothuis D; De Jong W; Debruyne F
    Chemioterapia; 1987 Jun; 6(2 Suppl):713-6. PubMed ID: 3334665
    [No Abstract]   [Full Text] [Related]  

  • 12. BCG in the management of superficial bladder cancer.
    Robinson MR
    Prog Clin Biol Res; 1985; 185B():161-6. PubMed ID: 3898140
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of bladder tumors].
    Njinou B; Dardenne B; Darimont M; Wese FX; Van Cangh PJ
    Acta Urol Belg; 1999; 67(1):6-10. PubMed ID: 10859816
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of Bacillus Calmette-Guerin in superficial bladder cancer: a review.
    Talug C; Brown ET; Zaslau S; Kandzari SJ
    W V Med J; 2009; 105(3):17-9. PubMed ID: 19456033
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravesical chemotherapy.
    Prout GR
    Prog Clin Biol Res; 1984; 162B():125-50. PubMed ID: 6438639
    [No Abstract]   [Full Text] [Related]  

  • 16. Resume of selected studies of the National Bladder Cancer Collaborative Group A and new protocols.
    Prout GR; Kopp J
    Prog Clin Biol Res; 1984; 162B():397-427. PubMed ID: 6438644
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk-adapted use of intravesical immunotherapy.
    Braasch MR; Böhle A; O'Donnell MA
    BJU Int; 2008 Nov; 102(9 Pt B):1254-64. PubMed ID: 19035890
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravesical chemotherapy and immunotherapy: how do we assess their effectiveness and what are their limitations and uses?
    Lamm DL; van der Meijden AP; Akaza H; Brendler C; Hedlund PO; Mizutani Y; Ratliff TL; Robinson MR; Shinka T
    Int J Urol; 1995 Jun; 2 Suppl 2():23-35. PubMed ID: 7553302
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of superficial carcinoma of the bladder.
    Paulson DF
    Prog Clin Biol Res; 1984; 162B():193-209. PubMed ID: 6209720
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic options in the management of intermediate-risk nonmuscle-invasive bladder cancer.
    Horvath A; Mostafid H
    BJU Int; 2009 Mar; 103(6):726-9. PubMed ID: 19007379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.